Initial Public Offering. A biotechnology company, Koros Therapeutics, completed its IPO on April 8, 2020, and listed on the Nasdaq. Keros sold 6,000,000 shares of stock to primary market investors at an IPO offer price of $15 41, with an underwriting ancount of 6.8%. Secondary market investors, however, were paying $21.97 por share for Kerok 19,189,391 shares of stock outstanding (which includes the newly-issued shares) a. Calculate the total proceeds for Keros IPO b. Calculate the dollar amount of the underwriting fee for Keros: IPO d. Calculate market capitalization for Koron outstanding stock e. Calculate IPO underpricing for Keros' IPO 1. Explain the IPO underpricing for Keros a. The total proceeds for Keros IPO is $. (Round to the nearest dolar)